🇺🇸 FDA
Patent

US 11925663

Methods of managing tumor flare in adoptive immunotherapy

granted A61KA61K2039/545A61K2039/585

Quick answer

US patent 11925663 (Methods of managing tumor flare in adoptive immunotherapy) held by Atara Biotherapeutics, Inc. expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Atara Biotherapeutics, Inc.
Grant date
Tue Mar 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K2039/545, A61K2039/585, A61K2239/31, A61K2239/38